Certified by Founder Lodge
RH Capital
United States - San Francisco, California
INVESTOR
1 Disclosed Funding Rounds $5,000,000
12 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
RH Capital, a Rhia Ventures fund, invests in early-stage high-impact companies that are driving innovation, access, and equity across the reproductive and maternal health landscape. As a wome
| Company | Date | Round | Raised |
|---|---|---|---|
AOA Dx |
October, 13 ,2023 | Unknown | $17,000,000 |
Eli Health |
April, 06 ,2023 | Unknown | $5,000,000 |
Mae |
May, 08 ,2024 | Seed | |
Evvy |
September, 28 ,2023 | Series A | $14,000,000 |
Raydiant Oximetry, Inc. |
June, 05 ,2024 | Series A | $7,500,000 |
AOA Dx |
October, 13 ,2023 | Unknown | $17,000,000 |
Novocuff, Inc. |
July, 18 ,2024 | Series A | $26,000,000 |
Mae |
May, 08 ,2024 | Seed | |
Raydiant Oximetry, Inc. |
June, 05 ,2024 | Series A | $7,500,000 |
Novocuff, Inc. |
July, 18 ,2024 | Series A | $26,000,000 |
Seven Starling |
August, 08 ,2024 | Series A | $10,900,000 |
Twentyeight Health |
January, 08 ,2025 | Series A | $10,000,000 |
AOA Dx
Eli Health
Mae
Evvy
Raydiant Oximetry, Inc.
Novocuff, Inc.
Seven Starling
Twentyeight Health
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
Syntracts | $5,300,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)